1 |
Ray MK, Fenton CG, Paulssen RH. Novel long non-coding RNAs of relevance for ulcerative colitis pathogenesis. Non-coding RNA Research 2022;7:40-7. [DOI: 10.1016/j.ncrna.2022.02.001] [Reference Citation Analysis]
|
2 |
Chen Y, Li H, Lai L, Huang Y, Shen J. Discovery of new long noncoding RNAs associated with ulcerative colitis with a novel general microarray expression data. Life Sci 2021;287:120090. [PMID: 34715141 DOI: 10.1016/j.lfs.2021.120090] [Reference Citation Analysis]
|
3 |
Rao J, Shao L, Lin M, Huang J, Fan L. LncRNA UCA1 Accelerates the Progression of Ulcerative Colitis via Mediating the miR-331-3p/BRD4 Axis. Int J Gen Med 2021;14:2427-35. [PMID: 34140798 DOI: 10.2147/IJGM.S304837] [Reference Citation Analysis]
|
4 |
Li H, Xuan J, Zhang W, An Z, Fan X, Lu M, Tian Y. Long non-coding RNA SNHG5 regulates ulcerative colitis via microRNA-375 / Janus kinase-2 axis. Bioengineered 2021;12:4150-8. [PMID: 34334085 DOI: 10.1080/21655979.2021.1953219] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
5 |
Chen S, He R, He B, Xu L, Zhang S. Potential Roles of Exosomal lncRNAs in the Intestinal Mucosal Immune Barrier. J Immunol Res 2021;2021:7183136. [PMID: 34485536 DOI: 10.1155/2021/7183136] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Sun L, Han Y, Wang H, Liu H, Liu S, Yang H, Ren X, Fang Y. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. J Int Med Res 2022;50:3000605221089503. [PMID: 35443818 DOI: 10.1177/03000605221089503] [Reference Citation Analysis]
|
7 |
Xing C, Liu XF, Zhang CF, Yang L. Hsp90-associated DNA replication checkpoint protein and proteasome-subunit components are involved in the age-related macular degeneration. Chin Med J (Engl) 2021;134:2322-32. [PMID: 34629418 DOI: 10.1097/CM9.0000000000001773] [Reference Citation Analysis]
|
8 |
Li F, Liu H, Fu J, Fan L, Lu S, Zhang H, Liu Z. Knockdown of long non-coding RNA NEAT1 relieves inflammation of ulcerative colitis by regulating the miR-603/FGF9 pathway. Exp Ther Med 2022;23:131. [PMID: 34970354 DOI: 10.3892/etm.2021.11054] [Reference Citation Analysis]
|